Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors.
about
The Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma.Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicThe HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabineReal-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer.Heat shock protein 70 - the next chaperone to target in the treatment of human acute myelogenous leukemia?Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.Panobinostat for the treatment of acute myelogenous leukemia.Role of HSP70 in motoneuron survival after excitotoxic stress in a rat spinal cord injury model in vitro.Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death.Regulating the cytoprotective response in cancer cells using simultaneous inhibition of Hsp90 and Hsp70.
P2860
Q33607950-40027331-37F2-4F14-A253-34AA32464047Q34817365-A67E29EE-6331-461A-BA10-FCC81AB5B52BQ35673943-F9615467-0D71-4B63-B029-0F83FFA80693Q38128358-8ECD1E35-F8BD-4E51-8949-5231629DAE30Q38222563-2510D251-0980-4829-A5F5-A7A85D455B93Q38401664-D3B32B80-2100-4F58-A270-F493CB3D33A3Q38435352-54E61A04-CDC8-4395-83A8-80E047B4DF52Q38755091-967F9C62-B260-4EA9-9216-02F7A459F4CBQ38835113-B1E19DAC-F84E-4816-9FFE-4A1F508AEB23Q38951024-22AAB4B8-BD56-46BD-A43F-08637FC5746DQ46038713-DFCCB2E3-D630-4748-B2A1-CD9A49F60DD0Q53663668-159079CC-39E7-4152-9007-65B9AB0E41DB
P2860
Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Increased antileukemic effects ...... ng HSP70 and HSP90 inhibitors.
@en
Increased antileukemic effects ...... ng HSP70 and HSP90 inhibitors.
@nl
type
label
Increased antileukemic effects ...... ng HSP70 and HSP90 inhibitors.
@en
Increased antileukemic effects ...... ng HSP70 and HSP90 inhibitors.
@nl
prefLabel
Increased antileukemic effects ...... ng HSP70 and HSP90 inhibitors.
@en
Increased antileukemic effects ...... ng HSP70 and HSP90 inhibitors.
@nl
P2093
P2860
P1476
Increased antileukemic effects ...... ng HSP70 and HSP90 inhibitors.
@en
P2093
André Sulen
Håkon Reikvam
Kimberley Joanne Hatfield
Øystein Bruserud
P2860
P304
P356
10.1517/13543784.2013.791280
P407
P577
2013-05-01T00:00:00Z